Stockreport

Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering

Enlivex Therapeutics Ltd. - Ordinary Shares  (ENLV) 
PDF Single healthcare-focused institutional investor $5 million upfront with up to an additional $10 million of gross proceeds upon the exercise in full of clinical mileston [Read more]